Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
- 1 September 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (3) , 679-688
- https://doi.org/10.1053/gast.2002.35393
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based studyGastroenterology, 2001
- ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's diseaseGastroenterology, 2001
- Anti-Saccharomyces Cerevisiae Antibodies (ASCA), Phenotypes of IBD, and Intestinal Permeability: A Study in IBD FamiliesInflammatory Bowel Diseases, 2001
- Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristicsGut, 2000
- Bacterial Regulation of Intestinal Immune ResponsesInflammatory Bowel Diseases, 2000
- A Simple Classification of Crohnʼs Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998Inflammatory Bowel Diseases, 2000
- Probiotics and inflammatory bowel diseasesAmerican Journal of Gastroenterology, 2000
- Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic ratsGastroenterology, 1999
- Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroupGastroenterology, 1996
- Frequency of glucocorticoid resistance and dependency in Crohn's disease.Gut, 1994